Robert Redfield
Vermogen: 96 034 $ op 30-06-2026
Vermogen: 96 034 $ op 30-06-2026
Robert Redfield is the founder of Prevention Diagnosis Treatment, Inc. President & Chief Executive Officer at R3 Enterprises & Consulting.
Director at Viriom, Inc. Senior Strategic Officer at Pasaca Capital, Inc. from 2021 to 2022.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Traws Pharma, Inc.
Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer 0,75% | 09-07-2026 | 113.919 ( 0,75% ) | 96 034 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
Viriom, Inc.
Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Pasaca Capital, Inc.
Pasaca Capital, Inc. Investment ManagersFinance Pasaca Capital invests in companies located in the United States. The firm focuses on a finance, government, IT and manufacturing sectors. It provides financing for growth capital requirements. | Corporate Officer/Principal | 01-01-2022 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 2 |
|---|---|
Viriom, Inc.
Viriom, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Pasaca Capital, Inc.
Pasaca Capital, Inc. Investment ManagersFinance Pasaca Capital invests in companies located in the United States. The firm focuses on a finance, government, IT and manufacturing sectors. It provides financing for growth capital requirements. | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau